top of page
Martin Burns joins Amicrobe's Board of Directors
SILVER SPRING, MD - AUGUST 20, 2019 - Dr. Michael Bevilacqua, Amicrobe’s founder and CEO, was an invited to participate as a panelist at the FDA workshop entitled "Understanding the Development of Non-Traditional Therapies for Bacterial Infection." The workshop focused on discussion of the landscape and important regulatory challenges associated with various areas of non-traditional therapies.
bottom of page